In this review:
CV outcomes with alirocumab after ACS
Efficacy of a wearable cardioverter-defibrillator after MI
CYP2C19 genotyping to guide antiplatelet therapy following PCI
1-year outcomes of the bio-engineered COMBO stent
Ticagrelor vs. clopidogrel in ACS with ST elevation treated with thrombolysis
Dabigatran for myocardial injury after noncardiac surgery (MINS)
Loading atorvastatin doses in ACS with planned revascularisation
Centrifugal-flow pump for circulatory support in advanced HF
Carvedilol for preventing chemotherapy-induced cardiotoxicity
6 vs. ≥12 months DAPT after PCI for ACS
Please login below to download this issue (PDF)